top of page

The Science: Complimentary Treatments

StiRx is focused on development of long-acting gonococcal mAb (STX-426) as PrEP and gonococcal bispecific antibody and vaccine (STX-428) for long term prevention, with a chlamydia bispecific antibody (STX-288) and other STI treatments in the exploratory phase of research.

science-graphics-30.png

Pre-Exposure Prophylaxis (PrEP) for repeat gonorrhea infections. For high-risk patients, potential use as long-acting immuno-prophylaxis.

science-graphics-17.png

Disease prevention in

all at-risk patient populations

bottom of page